Anat Loewestein

31PUBLICATIONS
43CO-AUTHORS
Major global burdens of diseaseRegenerative medicine (incl. stem cells)Gene and molecular therapyVision scienceOther education not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Mar 03, 2025
Biosimilar Ranibizumab (Ranieyes) Safety and Efficacy in the Real World: BRESER Study.

Ashish Sharma, Frank G Holz, Nilesh Kumar

|Feb 19, 2025
Aflibercept 2 mg biosimilars-will they lead the Anti-VEGF biosimilar world globally.

Ashish Sharma, Se Joon Woo, Christopher Seungkyu Lee

|Dec 19, 2024
Reply.

Elad Moisseiev, Anat Loewenstein

|Dec 13, 2024
Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration.

Anat Loewenstein, Michelle Sylvanowicz, Winfried M Amoaku

Pageof 6